IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BALSARI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.078
NA - Nord America 6.341
AS - Asia 4.822
SA - Sud America 289
AF - Africa 56
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 8
Totale 19.641
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.123
GB - Regno Unito 2.916
CN - Cina 2.532
IT - Italia 1.284
DE - Germania 913
SE - Svezia 861
SG - Singapore 698
IN - India 422
RU - Federazione Russa 403
UA - Ucraina 326
TR - Turchia 286
KR - Corea 285
IE - Irlanda 260
FR - Francia 205
BR - Brasile 176
CA - Canada 174
FI - Finlandia 174
NL - Olanda 163
JP - Giappone 150
DK - Danimarca 139
EU - Europa 116
VN - Vietnam 101
GR - Grecia 90
HK - Hong Kong 86
ID - Indonesia 85
ES - Italia 84
PL - Polonia 83
BE - Belgio 82
CO - Colombia 73
TW - Taiwan 47
AU - Australia 45
MX - Messico 37
IR - Iran 24
EG - Egitto 23
PH - Filippine 19
PT - Portogallo 19
RO - Romania 17
CH - Svizzera 12
HU - Ungheria 11
VE - Venezuela 11
AT - Austria 10
TH - Thailandia 10
AR - Argentina 9
BD - Bangladesh 9
MY - Malesia 9
ZA - Sudafrica 8
EC - Ecuador 7
LV - Lettonia 7
CY - Cipro 6
IL - Israele 6
MA - Marocco 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
DZ - Algeria 5
NG - Nigeria 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
IQ - Iraq 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CI - Costa d'Avorio 3
EE - Estonia 3
JO - Giordania 3
KZ - Kazakistan 3
MO - Macao, regione amministrativa speciale della Cina 3
NO - Norvegia 3
PS - Palestinian Territory 3
UY - Uruguay 3
AM - Armenia 2
AO - Angola 2
BO - Bolivia 2
KE - Kenya 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
TN - Tunisia 2
YE - Yemen 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GL - Groenlandia 1
KW - Kuwait 1
MD - Moldavia 1
MN - Mongolia 1
NP - Nepal 1
PY - Paraguay 1
UZ - Uzbekistan 1
Totale 19.752
Salva come PNG Salva come JPEG
Città #
Southend 2.698
Chandler 794
Milan 578
Seattle 481
Singapore 435
Fairfield 386
Beijing 343
Princeton 335
Wilmington 328
Ann Arbor 293
Frankfurt am Main 293
Ashburn 257
Dublin 252
Jacksonville 232
Woodbridge 201
Houston 200
Nanjing 186
Redmond 179
Dearborn 172
Shanghai 147
Guangzhou 145
Mountain View 143
Santa Clara 141
Cambridge 138
Grafing 117
Toronto 115
Boardman 106
Des Moines 105
Sakarya 103
Bengaluru 100
Athens 90
Shenyang 77
Jinan 73
Andover 70
Hangzhou 69
Serra 69
Bogotá 68
Phoenix 68
Warsaw 66
Changsha 62
Somerville 59
Jakarta 58
Zhengzhou 57
Wuhan 56
Brussels 55
Los Angeles 54
Nanchang 54
Chengdu 52
Redwood City 48
Tianjin 48
Hebei 44
Berlin 43
Helsinki 37
Fuzhou 36
Tokyo 35
Dong Ket 33
Bitonto 32
Shenzhen 31
Sunnyvale 30
San Diego 29
Turin 29
Taipei 28
Seoul 26
Hefei 24
São Paulo 24
Ningbo 22
Norwalk 22
Central 21
Jiaxing 21
New York 20
Eitensheim 19
Hanover 19
Ottawa 19
Auburn Hills 18
Boston 18
Fremont 18
Roxbury 18
Kunming 17
Madrid 17
San Francisco 17
Xiamen 17
Nuremberg 16
Prato 16
Bühl 15
Central District 15
Haikou 15
Lanzhou 15
Palermo 15
Falls Church 14
Groningen 14
Hong Kong 14
Odernheim 14
Rome 14
Sydney 14
Taiyuan 14
Chicago 13
Ciudad Obregón 13
Columbus 13
Harbin 13
Istanbul 13
Totale 12.310
Salva come PNG Salva come JPEG
Nome #
Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer 2.241
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-Small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade 630
Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases 341
Anti-tumor activity of CpG-ODN aerosol in mouse lung metastases 272
Local Administration of Caloric Restriction Mimetics to Promote the Immune Control of Lung Metastases 254
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors 219
The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy 213
Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion 210
Degranulation of paneth cells via toll-like receptor 9 204
Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis 204
Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation 193
Effect of adjuvant trastuzumab treatment in conventional clinical setting : an observational retrospective multicenter Italian study 187
Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia 181
HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy 177
Abstract in rivista: Role of Toll-like receptor 9 (TLR-9) in acute graft-versus-host disease 176
miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response 175
Exploiting poly(I:C) to induce cancer cell apoptosis 173
Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don’t) know 173
TLR9-agonists oppositely modulate DNA-repair genes in tumor versus immune cells and enhance chemotherapy effects 172
Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition 172
CpG-oligodeoxynucleotides induce mobilization of hematopoietic progenitor cells into peripheral blood in association with mouse KC (IL-8) production 169
Sodium-dependent glucose transporter-1 as a novel immunological player in the intestinal mucosa 167
Ascites regression and survival increase in mice bearing advanced-stage human ovarian carcinomas and repeatedly treated intraperitoneally with CpG-ODN 167
Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration 167
Doxorubicin-induced alopecia is associated with sebaceous gland degeneration 165
High efficacy of CpG-ODN, cetuximab and cisplatin combination for very advanced ovarian xenograft tumors 165
Low molecular weight hyaluronic acid increases the self defence of skin epithelium by induction of β-defensin 2 via TLR2 and 4 164
Allostimulation of patients' lymphocytes generates both T and NK-like cells cytotoxic for autologous melanoma 164
The influence of a fatty acids-free diet on breast cancer development in FVB/neu transgenic mice 163
Caveolin-1 is expressed on multipotent cells of hair follicles and might be involved in their resistance to chemotherapy 161
Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment 161
CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts 159
Activation of smooth muscle and myenteric plexus cells of jejunum via Toll-like receptor 4 155
Critical role of TLR9 in acute graft-versus-host disease 155
Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of beta-defensin 2 via TLR2 and TLR4 153
Therapeutic synergism of gemcitabine and CpG-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograft 153
Antibody response after vaccination with antigen-pulsed dendritic cells 151
Absence of the CD1 molecule up-regulates antitumor activity induced by CpG oligodeoxynucleotides in mice 150
Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress 149
Antitumor efficacy of trastuzumab in nude mice orthotopically xenografted with human pancreatic tumor cells expressing low levels of HER-2/neu 148
Apoptosis of hair follicle cells during doxorubicin-induced alopecia in rats 148
Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice 146
Epithelium-mesenchyme compartment interaction and oncosis on chemotherapy-induced hair damage 146
SGLT-1 as a novel immunological player in the intestinal mucosa 146
Aerosol 1,25-dihydroxyvitamin D3 supplementation: A strategy to boost anti-tumor innate immune activity 146
Toll-like receptor agonists regulate β-defensin 2 release in hair follicle 145
Cross-talk among Toll-like receptors and their ligands 144
Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer 143
Critical role of Toll-like receptor 9 in acute graft-versus-host disease 140
Prevention of spontaneous mammary adenocarcinoma in HER-2/neu transgenic mice by foreign DNA 138
CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2-specific T lymphocytes but do not lead to a protective tumor-specific memory response 138
Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages 137
Combination of a CpG-oligodeoxynucleotide and a topoisomerase I inhibitor in the therapy of human tumour xenografts 135
COMPOUNDS WITH GLYCIDIC STRUCTURE ACTIVE IN THE THERAPY OF SYSTEMIC AND LOCAL INFLAMMATION 135
Compound with glycidic structure active in the therapy of systemic and local inflammation 135
The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1 134
Low molecular weight hyaluronic acid increases the self defence of skin epithelium by induction of β-defensin 2 via TLR2 and 4 134
Induction of Paneth cell degranulation by orally administered toll-like receptor ligands 133
Influence of fatty acid-free diet on mammary tumor development and growth rate in HER-2/neu transgenic mice 133
Ascites regression and survival increase in mice bearing advanced-stage human ovarian carcinomas and repeatedly treated intraperitoneally with CpG-ODN 131
Stimulation of TLRs by LMW-HA induces self-defense mechanisms in vaginal epithelium 130
COMPUESTOS GLUCOPIRANOSIDOS UTILES PARA TRATAR DIABETES MELLITUS, ENFERMEDADES INFLAMATORIAS Y/O ALERGICAS, Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN 130
Fluctuation of HER2 expression in breast carcinomas during the menstrual cycle 129
Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS 127
Toll-like receptor agonists regulate beta-defensin 2 release in hair follicle 127
Aerosol delivery in the treatment of lung cancer 126
Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patients 125
Inhibition of DNA Repair Mechanisms and Induction of Apoptosis in Triple Negative Breast Cancer Cells Expressing the Human Herpesvirus 6 U94 123
FOXP3 expression and overall survival in breast cancer 122
SGLT-1 as a novel immunological player in the intestinal mucosa 122
EGFR through STAT3 is a player in ΔNp63α expression and together sustain tumor-initiating cell proliferation in squamous cell carcinomas 122
COMPOSTI A STRUTTURA GLICOSIDICA ATTIVI NELLA TERAPIA DI STATI INFIAMMATORI LOCALI E SISTEMICI 121
Intestinal glucose uptake protects liver from lipopolysaccharide and d-galactosamine, acetaminophen, and alpha-amanitin in mice 117
Maspin influences response to doxorubicin by changing the tumor microenvironment organization 115
Relevant role of repeated intreperitoneally treatment with CpG-ODN in mice bearing advanced-stage of human ovarian carcinomas 113
Influence of lignans depletion on murine mammary gland morphology 111
EGFR through STAT3 modulates ΔN63α expression to sustain tumor-initiating cell proliferation in squamous cell carcinomas 111
Enhanced antitumour efficacy of gimatecan in combination with Bcl-2 antisense oligonucleotide in human melanoma xenografts 110
Dansyl C-glucoside as a novel agent against endotoxic shock 110
USO DI MONOSACCARIDI COME IMMUNOMODULANTI 108
Reprogramming the lung microenvironment by inhaled immunotherapy fosters immune destruction of tumor 108
Eradication of ovarian tumor xenografts by locoregional administration of targeted immunotherapy 106
Apoptosis induction by trastuzumab: Possible role of the core biopsy intervention 105
Activity and resistance of trastuzumab according to different clinical settings 105
Topical administration of a doxorubicin-specific monoclonal antibody prevents drug-induced mouth apoptosis in mice 105
Expression and prognostic significance of the autoimmune regulator gene in breast cancer cells 103
Chemotherapy can enhance trastuzumab-mediated ADCC 101
Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34+ cells in a xenograft model 100
Linking survival of HER2-positive breast carcinoma patients with surgical invasiveness 99
Role of exon-16-deleted HER2 in breast carcinomas 99
A monoclonal antibody extends the half-life of an anti-HIV oligodeoxynucleotide and targets it to CD4+ cells 99
PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells 99
Macrophages impair TLR9 agonist antitumor activity through interacting with the anti-PD-1 antibody Fc domain 99
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score 97
HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer 97
Cross-talk between tool-like receptors 5 and 9 on activation of human immune responses 96
TLR3 expression induces apoptosis in human non‐small‐cell lung cancer 96
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung : a phase I study 95
Role of HER2 in wound-induced breast carcinoma proliferation 94
Innate immunity in breast carcinoma 93
Totale 16.935
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.702
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.064 0 0 0 0 0 0 0 124 377 340 136 87
2020/20212.296 69 150 199 110 195 139 137 114 341 137 529 176
2021/20222.748 220 174 148 188 260 219 232 235 255 181 228 408
2022/20232.835 341 326 229 311 322 482 69 169 305 57 110 114
2023/20242.150 137 219 153 217 341 127 121 159 83 147 216 230
2024/20251.969 201 386 161 398 285 237 213 88 0 0 0 0
Totale 21.005